Contraception
Volume 81, Issue 3 , Pages 202-208 , March 2010

Epidemiological and clinical aspects of migraine in users of combined oral contraceptives

Received 5 June 2009 ,Revised 13 August 2009 ,Accepted 15 September 2009.

References 

  1. Rasmussen BK. Epidemiology of headache. Cephalalgia. 1995;15:45–68
  2. Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache. 2001;41:638–645
  3. MacGregor A. Migraine associated with menstruation. Funct Neurol. 2000;15(Suppl 3):143–153
  4. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders: 2nd edition. Cephalalgia. 2004;24(suppl 1):9–160
  5. Curtis KM, Mohllajee AP, Peterson HB. Use of combined oral contraceptives among women with migraine and nonmigrainous headaches: a systematic review. Contraception. 2006;73:189–194
  6. Loder EW, Buse DC, Golub JR. Headache as a side effect of combination estrogen–progestin oral contraceptives: a systematic review. Am J Obstet Gynecol. 2005;193(3 Pt 1):636–649
  7. Sulak P. Ovulation suppression of premenstrual symptoms using oral contraceptives. Am J Manag Care. 2005;11(16 Suppl):S492–S497
  8. Calhoun AH. Migraine and menopause. Headache. 2004;44:106
  9. Edelson RN. Menstrual migraine and other hormonal aspects of migraine. Headache. 1985;25:376–379
  10. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41:646–657
  11. MacGregor EA, Hackshaw A. Prevalence of migraine on each day of the natural menstrual cycle. Neurology. 2004;63:351–353
  12. Neri I, Granella F, Nappi R, Manzoni GC, Facchinetti F, Genazzani AR. Characteristics of headache at menopause: a clinico-epidemiologic study. Maturitas. 1993;17:31–37
  13. Stein GS. Headaches in the first post partum week and their relationship to migraine. Headache. 1981;21:201–205
  14. Aegidius K, Zwart JA, Hagen K, Schei B, Stovner LJ. Oral contraceptives and increased headache prevalence: the Head-HUNT Study. Neurology. 2006;66:349–353
  15. Fotherby K. Twelve years of clinical experience with an oral contraceptive containing 30 micrograms ethinyloestradiol and 150 micrograms desogestrel. Contraception. 1995;51:3–12
  16. Fotherby K. Clinical experience and pharmacological effects of an oral contraceptive containing 20 micrograms estrogen. Contraception. 1992;46:477–488
  17. Kelman L. The aura: a tertiary care study of 952 migraine patients. Cephalalgia. 2004;24:728–734
  18. Ernst U, Baumgartner L, Bauer U, Janssen G. Improvement of quality of life in women using a low-dose desogestrel containing contraceptive: results of an observational clinical evaluation. Eur J Contracept Reprod Health Care. 2002;7:238–243
  19. Brill K, Schnitker J, Albring M. Long-term experience with a low-dose oral contraceptive. Gynecol Endocrinol. 1990;4:277–286
  20. Sulak PJ, Scow RD, Preece C, Riggs M, Kuehl TJ. Hormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol. 2000;95:261–266
  21. Sulak P, Willis S, Kuehl T, Coffee A, Clark J. Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval. Headache. 2007;47:27–37
  22. LaGuardia KD, Fisher AC, Bainbridge JD, LoCoco JM, Friedman AJ. Suppression of estrogen-withdrawal headache with extended transdermal contraception. Fertil Steril. 2005;83:1875–1877
  23. Cupini LM, Matteis M, Troisi E, Calabresi P, Bernardi G, Silvestrini M. Sex-hormone-related events in migrainous females. A clinical comparative study between migraine with aura and migraine without aura. Cephalalgia. 1995;15:140–144
  24. Granella F, Sances G, Pucci E, Nappi RE, Ghiotto N, Napp G. Migraine with aura and reproductive life events: a case–control study. Cephalalgia. 2000;20:701–707
  25. MacGregor EA. Migraine, the menopause and hormone replacement therapy: a clinical review. J Fam Plann Reprod Health Care. 2007;33:245–249
  26. Genazzani AR, Pluchino N, Begliuomini S, et al. Drospirenone increases central and peripheral beta-endorphin in ovariectomized female rats. Menopause. 2007;14:63–73
  27. Vujović S, Zidverc J, Stojanović M, et al. Drospirenone in the treatment of severe premenstrual cerebral edema in a woman with antiphospholipid syndrome, lateral sinus thrombosis, situs inversus and epileptic seizures. Gynecol Endocrinol. 2005;21:243–247

☆ A.P. Pinheiro, L. Neri and L. Martins received a scientific initiation grant from CNPQ-PIBIC Faculdade de Medicina de Jundiaí, Brazil.

PII: S0010-7824(09)00416-8

doi: 10.1016/j.contraception.2009.09.006

Contraception
Volume 81, Issue 3 , Pages 202-208 , March 2010

Article Tools

* Image Usage & Resolution